99.4 (90.9 -100) 100 2,2 ', 3, 3', 4, 4', 5, 93.8 (64.3 -100) 91.4 (60 -100)
Persistent Pesticides
Hexachlorobenzene (HCB) 99.1 (85.7 -100) 100 2,2-Bis(4-chlorophenyl)-1,1-dichloroethene (PP-DDE) 100 100 
2.3 ± 0.3 2.9 ± 1.8 2.3 ± 1.3 1.9 ± 0.7 2.5 ± 0.8 2. 
50.7 ± 15.6 46.8 ± 9.5 74.9 ± 16.9 51.3 ± 12.0 62.5 ± 35.4 59.0 ± 40.0 
20-39
2003-04 39.6 ± 19.9 37.7 ± 10.2 53.5 ± 25.6 106.4 ± 145.5 40.7 ± 16.8 43.0 ± 28.1
30.4 ± 8.9 41.2 ± 7.8 61.0 ± 44.8 42.8 ± 26.9 50.0 ± 37.3 46.1 ± 43.4
31.2 ± 20.5 33.9 ± 11.3 32.2 ± 8. 
25.4 ± 8.5 36.4 ± 9.9 59.0 ± 72.7 29.6 ± 18.3 22.5 ± 11.5 21.
23.0 ± 6.4 37.4 ± 18.7 20.9 ± 6.2 30.5 ± 13.1 20.5 ± 7.5 38.7 ± 25.4 
37.8 ± 4.7 41.5 ± 15.1 46.4 ± 20.9 31.8 ± 8.9 40.4 ± 12.5 40.1 ± 19.5 
12-19
2003-04 11.3 ± 2.5 16.1 ± 4.2 9.8 ± 1.5 15.7 ± 6.7 10.8 ± 5.5
10.7 ± 2.9 9.3 ± 1.7 23.3 ± 5.8 12.6 ± 3.0 17.5 ± 12.0 14.6 ± 10.0
7.0 ± 2.6 10.7 ± 5.6 17.6 ± 12.8 7.4 ± 4.7 8.1 ± 5.6 6.8 ± 2.9 --- 
6.5 ± 1.6 8.5 ± 1.8 17.5 ± 16.0 16.5 ± 19.3 13.4 ± 11.0 10.3 ± 10.1
6.4 ± 5.1 7.8 ± 3.0 7.2 ± 2.3 6.3 ± 2.6 7.7 ± 4.5
2003-04 8.9 ± 3.0 19.0 ± 26.8 15.6 ± 12.4 23.9 ± 14.7 9.4 ± 5.1 11.9 ± 6.8
6.3 ± 4.7 9.1 ± 3.3 16.1 ± 24.7 5.7 ± 2.9 4.2 ± 2.0 4.4 ± 1.9
4.5 ± 1.3 6.9 ± 4.7 4.3 ± 1.6 7.2 ± 3.6 4.4 ± 2.0 9.9 ± 7.6 ---
2003-04 10.7 ± 2.3 7.3 ± 2.3 15.3 ± 8.2 12.7 ± 6.5 9.4 ± 2.0 15.9 ± 11.6 ---
13.0 ± 5.4 7.5 ± 2.9 11.2 ± 7.3 19.5 ± 22.8 12.3 ± 6.9 15.4 ± 12.1 --- 2,2',3,4,4'-Tentabromodiphenyl ether (PBDE85)   2,2',4,4' ,5-Pentabromodiphenyl ether (PBDE99) 
9.5 ± 3.0 8.9 ± 2.1 14.2 ± 5.0 10.8 ± 2.3 10.8 ± 4.9 13.1 ± 11.
6.4 ± 3.7 11.0 ± 5.8 10.2 ± 8.3 6.5 ± 2.5 6.0 ± 1.9 5.7 ± 2.7 ---
20-39
2003-04 6.5 ± 3.0 6.1 ± 1.7 8.6 ± 4.0 17.4 ± 20.7 10.1 ± 4.0 8.9 ± 4.9 ---
5.4 ± 1.9 8.9 ± 3.0 11.7 ± 11.6 9.1 ± 7.2 9.9 ± 5.7
7.5 ± 4.7 7.7 ± 3.0 7.4 ± 2.9 7.2 ± 3.2 6.1 ± 2.1 
6.0 ± 2.2 7.9 ± 3.6 10.4 ± 13.2 7.2 ± 4.9 4.1 ± 1.9
2003-04 8.3 ± 1.1 9.2 ± 3.1 10.4 ± 3.6 8.6 ± 3.9 9.9 ± 2.2 13.8
10.2 ± 2.7 6.7 ± 2.6 8.0 ± 4.0 12.1 ± 6.6 12.8 ± 7.0 14.2 ± 7.6 ---
7.9 ± 1.1 9.5 ± 7.4 8.5 ± 3.4 6.6 ± 2.0 8.1 ± 2.2 7.8 ± 4.0
12-19
2003-04 8.8 ± 1.6 17.5 ± 9.6 9.7 ± 2.3 24.2 ± 7.7 11.1 ± 4.9 22.8 ± 17.0
10.5 ± 3.1 11.0 ± 3.5 12.1 ± 3.1 16.5 ± 2.4 12.8 ± 6.0 18.0 ± 12.
7.1 ± 2.1 17.2 ± 19.5 11.1 ± 5.2 20.7 ± 7.2 8.8 ± 2.7 13.8 ± 7.3 ---
20-39
2003-04 6.0 ± 2.4 9.8 ± 5.9 8.4 ± 3.4 16.2 ± 11.6 17.5 ± 6.2 19.1 ± 7.8 ---
6.7 ± 3.8 11.9 ± 7.1 9.6 ± 4.3 10.3 ± 5.6 11.1 ± 4.0 15.4 ± 8.0
11.1 ± 6.2 10.7 ± 5.7 11.0 ± 4.1 13.4 ± 9.8 11.8 ± 3.6 20.9 ± 6.6 ---
40-59
2003-04 8.1 ± 3.6 9.2 ± 5.9 8.9 ± 5.8 22.2 ± 11.4 9.3 ± 4.3 24.4 ± 21.6 ---
9.2 ± 4.0 11.3 ± 11.2 7.4 ± 5.4 13.4 ± 9.1 10.4 ± 5.8 7.5 ± 2.6 ---
6.5 ± 3.0 11.9 ± 5.7 6.3 ± 2.4 10.2 ± 2.5 9.9 ± 4.4 16.0 ± 7.5 ---
2003-04 9.1 ± 2.5 12.7 ± 4.6 8.0 ± 2.5 8.6 ± 3.6 15.6 ± 5.4 25.4 ± 9.9 ---
11.0 ± 4.3 8.0 ± 3.8 6.9 ± 4.8 14.7 ± 4.1 9.6 ± 5.3 19.7 ± 9.1 ---
10.2 ± 5.7 17.6 ± 10.3 7.9 ± 3.5 10.6 ± 3.8 13.2 ± 4.5 14.7 ± 7. 
1.5 ± 0.5 1.6 ± 0.2 2.9 ± 0.9 2.3 ± 0.8 2.6 ± 0.5 2.6 ± 0.9
2003-04 6.4 ± 3.5 4.3 ± 0.9 11.2 ± 1.6 7.3 ± 4.2 8.0 ± 0.7 6.6 ± 1.
4.3 ± 0.9 2.9 ± 0.8 8.7 ± 1.9 4.5 ± 2.2 7.2 ± 0.9 5.3 ± 0.9
2003-04 13.9 ± 2.8 6.2 ± 1.5 38.3 ± 9.1 26.2 ± 11.0 20.0 ± 3.2 12.2 ± 1.5 NHB ↑ NHW ↑ NHB ↑ NHB ↑ NHW ↑ NHB ↑ Females ↑ ---Females ↑ 2005-06 11.9 ± 5.4 6.4 ± 1.9 36.0 ± 21.6 16.5 ± 6.5 17.8 ± 3.5 11.7 ± 2.5 ---------NHB ↑ NHW ↑ ---------Females ↑ 2007-08 9.7 ± 3.8 6.5 ± 2.0 21.5 ± 4.3 11.5 ± 3.2 15.8 ± 2.2 10.5 ± 1.8 NHB ↑ NHW ↑ ------NHW ↑ ------Females ↑Females ↑ 12-19 2003-04 2.0 ± 0.4 2.1 ± 0.2 2.7 ± 0.6 3.4 ± 0.4 2.9 ± 0.6 2.8 ± 0.8
0.8 ± 0.1 0.9 ± 0.2 1.4 ± 0.3 2.1 ± 0.5 1.3 ± 0.2 1.5 ± 0.7
0.7 ± 0.2 0.8 ± 0.3 1.2 ± 0.7 1.4 ± 0.3 0.9 ± 0.6 1.5 ± 0.7 ---
20-39
2003-04 2.1 ± 0.4 2.3 ± 0.4 4.9 ± 1.4 3.9 ± 0.9 3.5 ± 0.8 3.6 ± 0.5
1.1 ± 0.4 1.5 ± 0.3 2.4 ± 0.7 2.5 ± 0.6 1.9 ± 0.4 2.6 ± 0.8
40-59
2003-04 5.4 ± 3.9 3.8 ± 0.7 10.7 ± 2.1 8.7 ± 3.1 6.4 ± 1.1 6.7 ± 1.7 ---
3.3 ± 0.8 2.4 ± 0.5 7.6 ± 1.8 5.5 ± 2.2 4.5 ± 0.7 4.3 ± 0.9 NHB ↑ ---
2.7 ± 0.6 3.2 ± 1.3 6.4 ± 1.7 6.2 ± 3.2 3.9 ± 0.6 3.
2003-04 7.0 ± 0.8 5.0 ± 0.9 31.5 ± 7.4 25.2 ± 13.4 12.7 ± 4.6 8.5 ± 1.8 NHB ↑ NHW ↑ NHB ↑ NHB ↑ NHW ↑ NHB ↑ Females ↑ ------2005-06 5.7 ± 1.8 4.2 ± 0.8 21.5 ± 13.3 14.2 ± 5.7 10.0 ± 1.9 8.0 ± 1.6 NHB ↑ NHW ↑ ---NHB ↑ NHW ↑ ------------2007-08 5.2 ± 1.6 4.5 ± 1.0 17.9 ± 6.0 11.5 ± 3.1 8. 2,4,4',5-Tetrachlorobiphenyl (PCB74)   2,2',4,4',5-Pentachlorobiphenyl (PCB99 )   Table S8 . Arithmetic mean concentration (ng/g lipid) of 2,3',4,4',5-pentachlorobiphenyl (PCB118) and 2,2 ', 3, 4, 4', 3, 3', 4, 4', in pooled serum samples from NHANES participants by age group, survey period, ethnicity, and sex with 95% confidence interval (95%CI). All pairwise comparisons between each ethnic group within each sex group and between each sex within ethnic group have been given. ↑ indicates significant higher concentration compared with comparison group (non-overlap of 95%CI).
MA/NHB MA/NHW NHB/NHW MA/NHB MA/NHW NHB/NHW MA NHB NHW

12-19
2003-04 2.7 ± 0.5 2.6 ± 0.3 3.6 ± 1.0 3.9 ± 0.5 4.0 ± 1.1 3.6 ± 0.9 ---
3.3 ± 0.6 3.0 ± 0.6 5.9 ± 1.5 4.2 ± 1.4 5.2 ± 1.1
1.9 ± 0.6 2.2 ± 0.4 3.7 ± 1.4 2.6 ± 1.5
2.5 ± 0.5 2.7 ± 0.6 3.4 ± 0.9 2.8 ± 1.1
40-59
2003-04 11.7 ± 9.3 6.7 ± 1.3 15.6 ± 2.4 14.1 ± 12.3 9.9 ± 2.3
6.8 ± 1.6 4.1 ± 0.8 11.7 ± 1.9 7.3 ± 6.9 7.8 ± 2.1 7.6 ± 2.8
6.1 ± 2.0 6.0 ± 1.7 11.2 ± 2.8 7.3 ± 4.7 7.6 ± 1.9
2003-04 17.8 ± 2.0 9.0 ± 3.4 56.4 ± 15.1 32.5 ± 15.2 26.6 ± 6.9 14.7 ± 2.9 NHB ↑ ---
15.3 ± 6.7 8.1 ± 2.7 45.0 ± 28.0 19.9 ± 10.6 21.9 ± 4.4 13.3 ± 3.4 ---
14.0 ± 3.9 8.7 ± 1.9 35.1 ± 9.1 16.1 ± 4.3 21.5 ± 6.0 15.5 ± 3.6 NHB ↑ ------NHB ↑ NHW ↑ ------Females ↑ ---12-19 2003-04 3.8 ± 0.5 4.6 ± 0.8 6.2 ± 1.3 7.7 ± 1.1 6.3 ± 1.6 6.5 ± 1.7
1.9 ± 0.4 2.7 ± 1.0 3.0 ± 0.5 4.8 ± 1.2 3.2 ± 0.8
1.8 ± 1.5 2.6 ± 1.8 3.3 ± 1.6 4.6 ± 1.5 3.5 ± 2.0 4.8 ± 3.0
20-39
2003-04 5.6 ± 1.2 7.1 ± 1.8 12.5 ± 3.5 12.4 ± 4.8 11.4 ± 3.1 13.5 ± 2.8
3.2 ± 1.1 4.5 ± 0.8 6.9 ± 2.5 7.7 ± 3.4 5.2 ± 0.9 8.0 ± 2.9 NHB ↑ ---
4.4 ± 0.6 5.7 ± 1.5 7.2 ± 2.5 7.9 ± 2.3 7.9 ± 4.4 8.7 ± 1.6 --- 
12.5 ± 2.3 9.7 ± 1.6 25.5 ± 6.4 20.9 ± 8.4 16.5 ± 2.5 19.6 ± 6.9 NHB ↑ ---
14.6 ± 4.2 15.2 ± 4.5 28.2 ± 7.0 28.6 ± 14.5 21.5 ± 2.4 20.7 ± 4.3 
25.6 ± 13.1 23.9 ± 6.9 79.9 ± 15.5 68.2 ± 21.6 45.0 ± 6.4 47.5 ± 9.1 NHB ↑ --- 2,3',4,4',5-Pentachlorobiphenyl (PCB118)   2,2',3,4,4',5'-and 2,3,3',4,4',6-Hexachlorobiphenyl (PCB138-158 
4.7 ± 1.9 6.9 ± 0.9 10.8 ± 4.1 13.8 ± 6.6 8.5 ± 1.9 13.2 ± 5.4
5.6 ± 1.2 6.8 ± 1.7 9.0 ± 3.2 10.3 ± 2.9 9.4 ± 4.6 11.0 ± 2.1 --- 
1.8 ± 0.4 2.0 ± 0.8 2.1 ± 0.3 4.1 ± 1.3 2.7 ± 0.6 4.2 ± 1.4
2.1 ± 3.9 2.2 ± 1.2 2.0 ± 0.7 3.5 ± 1.8 2.8 ± 2.1 3.5 ± 1.4 
3.4 ± 1.9 5.1 ± 0.7 6.9 ± 3.2 10.5 ± 4.1 6.4 ± 2.2 10.7 ± 6.1 ---------NHB ↑ ---------------2007-08
3.9 ± 0.7 5.5 ± 1.6 5.7 ± 2.6 7.4 ± 2.6 6.7 ± 2.8 8.4 ± 1.4 ---------------------------40-59 2003-04 16.7 ± 4.1 28.0 ± 11.3 36.6 ± 10.2 50.0 ± 18.6 28.8 ± 3.6 33.4 ± 7.2 NHB ↑ NHW ↑ ---------------------2005-06 15.5 ± 2.7 15.9 ± 4.2 30.5 ± 10.1 32.8 ± 8.0 22.4 ± 2.5 37.8 ± 24.9 NHB ↑ NHW ↑ ---NHB ↑ ---------------2007-08 18.2 ± 5.1 20.9 ± 6.6 26.4 ± 7.9 34.2 ± 12.7 22.3 ± 2.2 25.8 ± 3.7 --- 2,2',4,4',5,5'-Hexachlorobiphenyl (PCB153)   2,2',3,4,4',5,5'-Heptachlorobiphenyl (PCB180) Table S10. Arithmetic mean concentration (ng/g lipid) of 2,2',3,3',4,4',5,5'-octachlorobiphenyl (PCB194) in pooled serum samples from NHANES participants by age group, survey period, ethnicity, and sex with 95% confidence interval (95%CI). All pairwise comparisons between each ethnic group within each sex group and between each sex within ethnic group have been given. ↑ indicates significant higher concentration compared with comparison group (non-overlap of 95%CI). 2003-04 0.9 ± 0.5 1.5 ± 0.7 1.5 ± 0.5 2.7 ± 1.3 2.1 ± 0.6 3.7 ± 1.9 ---NHW ↑ ---------------------2005-06 0.6 ± 0.3 1.0 ± 0.2 1.3 ± 0.6 2.2 ± 0.9 1.3 ± 0.4 2.3 ± 1.5 ---------NHB ↑ ---------------2007-08 0.9 ± 0.2 1.8 ± 1.5 1.1 ± 0.8 1.8 ± 0.6 1.6 ± 0.4 1.9 ± 0.5 ---NHW ↑ ---------------------
MA/NHB
